1 Bell, J.G., Tocher, D.R., and Sargent, J.R. Effect of supplementation with 20:3(n-3), 20:4(n-6) and 20:5(n-3) on the production of prostaglandins E and F of the 1-, 2- and 3-series in turbot (Scophthalmus maximus) brain astroglial cells in primary culture. Biochim Biophys Acta 1211 335-342 (1994).

2 Levin, G., Duffin, K.L., Obukowicz, M.G., et al. Differential metabolism of dihomo-γ-linolenic acid and arachidonic acid by cyclo-oxygenase-1 and cyclo-oxygenase-2: Implications for cellular synthesis of prostaglandin E₁ and prostaglandin E₂. Biochem J 365 489-496 (2002).

3 Kawashima, H., Tateishi, N., Shiraishi, A., et al. Oral administration of dihomo-γ-linolenic acid prevents development of atopic dermatitis in NC/Nga mice. Lipids 43(1) 37-43 (2007).

4 Takai, S., Jin, D., Kawashima, H., et al. Anti-atherosclerotic effects of dihomo-γ-linolenic acid in ApoE-deficient mice. J Atheroscer Thromb 16(4) 480-489 (2009).

Schalin-Karrila, M., Mattila, L., Jansen, C.T., et al. Evening primrose oil in the treatment of atopic eczema: Effect on clinical status, plasma phospholipid fatty acids, and circulating blood prostaglandins. Br J Dermatol 117 11-19 (1987).

Yagaloff, K.A., Franco, L., Simko, B., et al. Essential fatty acids are antagonists of the leukotriene B₄ receptor. Prostaglandins Leukot Essent Fatty Acids 52 293-297 (1995).

Dihomo-γ-Linolenic Acid is available in the following screening libraries:

• Fatty Acid Screening Library (96-Well)
• Bio-active Lipid I Screening Library (96-Well)